When estrogen treated breast cancer cells are irradiated there is partial activation of p53 and its downstream pathways, but the pro-proliferative effects of estrogen override any checkpoint-mediated cell cycle arrest (20). The gene discussed is TP53; the disease is breast carcinoma.